Cargando…
Enabling allogeneic therapies: CIRM‐funded strategies for immune tolerance and immune evasion
A major goal for the field of regenerative medicine is to enable the safe and durable engraftment of allogeneic tissues and organs. In contrast to autologous therapies, allogeneic therapies can be produced for many patients, thus reducing costs and increasing availability. However, the need to overc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445020/ https://www.ncbi.nlm.nih.gov/pubmed/32585084 http://dx.doi.org/10.1002/sctm.20-0079 |